Efficacy of antiviral therapy for the prevention of mother‐to‐child transmission of hepatitis B virus and the risk of postpartum hepatitis flare after discontinuation of antiviral therapy

Documenti analoghi

• Factors associated with low hepatitis B surface antigen levels in chronic hepatitis B patients treated with nucleot(s)ide analogs
  di: Takanori Suzuki, et al.
  Pubblicazione: (2024)
• Sacubitril/Valsartan Attenuates Inflammation and Fibrosis Associated With Decreased Integrin α8 and Inhibits Hepatocarcinogenesis in a Rat Model of Metabolic Dysfunction‐Associated Steatohepatitis
  di: Hayato Kawamura, et al.
  Pubblicazione: (2025)
• Factors involved in gastroesophageal varix‐related events in patients with hepatitis C virus‐related compensated and decompensated cirrhosis after direct‐acting antiviral therapy
  di: Yuki Tahata, et al.
  Pubblicazione: (2024)
• Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis
  di: Takanori Suzuki, et al.
  Pubblicazione: (2025)
• Current insights into pathogenesis and anti‐inflammatory treatment strategies for severe alcohol‐associated hepatitis: focus on neutrophil‐targeted therapies
  di: Ryosuke Kasuga, et al.
  Pubblicazione: (2025)